Clinical Trials Logo

Type2 Diabetes clinical trials

View clinical trials related to Type2 Diabetes.

Filter by:

NCT ID: NCT05177250 Recruiting - Type2 Diabetes Clinical Trials

Association of Bisphenol A,Paraben Exposure and Type 2 Diabetes

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the association between BPA , paraben levels and type 2 DM patients

NCT ID: NCT05176847 Active, not recruiting - Clinical trials for Overweight and Obesity

The Mobile Lifestyle Intervention for Food and Exercise Study

mLIFE
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The goal of the study is to examine long term sustained weight loss digital intervention in a diverse cohort of adults with overweight/obesity. The intervention includes social gaming (using game-like elements in nongame contexts to promote supportive social interactions and openness to positive behavioral influences) to reward behaviors, such as self-monitoring and social support. Investigators will accomplish objectives and test hypotheses by following two specific primary aims: 1. Determine if the intervention plus gaming produces significantly more weight loss at 12 months than the same intervention without gaming among 240 adults with overweight or obesity and ≥3 T2DM risk factors. 2. Examine the differences in social support provision and receipt between groups at 12 months.

NCT ID: NCT05160272 Recruiting - Type2 Diabetes Clinical Trials

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes

Start date: January 7, 2022
Phase: Phase 2
Study type: Interventional

The aim of this single-center, prospective, randomized, double-blind, placebo-controlled, 2-arm parallel-group interventional study is to investigate the effect of 4-week treatment with AP-325 on C-peptide release as measure of insulin secretion compared to placebo in type 2 diabetes (T2D) patients.

NCT ID: NCT05147116 Completed - Type2 Diabetes Clinical Trials

The Effect of Hypoxia on Type 2 Diabetes and Weight Loss

Start date: February 17, 2022
Phase: N/A
Study type: Interventional

The number of people with type 2 diabetes mellitus (T2DM) continuing to rise, this pandemic is expected to reach 700 million people by 2045. T2DM is a metabolic condition characterized by progressive insulin resistance and chronic hyperglycemia (high blood glucose concentrations). Hyperglycaemia increases the risk of both micro- and macrovascular damage, whilst interventions that reduce blood glucose mitigate this risk. Weight loss, achieved through exercise and dietary modification, is effective at reducing hyperglycaemia. However, despite the clear benefits of exercise and weight loss, diverse psychological, sociological and logistical factors can make it difficult for some individuals with T2DM to initiate, or adhere to, these lifestyle interventions. Alternative approaches to treatment are therefore required. The purpose of this research project is to investigate whether 10-days of overnight exposure to moderate hypoxia is effective at improving blood glucose control in individuals with T2DM and to provide insight into the physiological mechanisms responsible for any beneficial effects.

NCT ID: NCT05110846 Active, not recruiting - Obesity Clinical Trials

A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Start date: February 22, 2022
Phase: Phase 2
Study type: Interventional

A Study to Assess the effect of CT-868 in hemoglobin A1c (HbA1c) in Overweight and Obese Participants with Type 2 Diabetes Mellitus.

NCT ID: NCT05106231 Completed - Diabetes Mellitus Clinical Trials

Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education

EPICCIHKDMEP
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The Ministry of Health Malaysia designs an education program for diabetes mellitus under the "Know Your Medicine" campaign. The Pharmacy Integrated Community Care (PICC) program hopes to improve knowledge and self-care for diabetes mellitus patients. PICC contains four modules that will provide knowledge on diabetes mellitus in an interactive, easily understandable and fun program. The investigators want to evaluate the program's effectiveness to see its relevance to Malaysian. PICC is an education program to give knowledge on diabetes mellitus to patients. It intended to improve self-care knowledge for patients with underlying Type 2 Diabetes Mellitus conducted the whole of Malaysia. However, in Sarawak, the investigators interested in conducting it together with this is an experimental study aiming to examine PICC's effectiveness. The study is being conducted in the nine Sarawak divisions. A minimum of 94 respondents will be participating in this study. Patient profile details will be taken with strict confidentiality.

NCT ID: NCT05094401 Terminated - Type2 Diabetes Clinical Trials

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

Start date: October 4, 2021
Phase: Phase 3
Study type: Interventional

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers a type of behavioral therapy to patients via a mobile application that targets behaviors related to achieving glycemic control. The effectiveness of BT-001 will be measured by its ability to help patients reduce Hemoglobin A1c, or HbA1c (a marker in the blood that measures blood sugar) in patients with type 2 diabetes.

NCT ID: NCT05092399 Recruiting - Obesity Clinical Trials

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

BARIATRICMRI
Start date: July 1, 2022
Phase:
Study type: Observational

The investigators are therefore interested to explore the effects of VLCD and different bariatric surgery procedures to changes in the physical deposition of fat in organs which regulate glucose metabolism (i.e. in the liver, pancreas, muscle) in the earlier (6 weeks) and intermediate (4 months) period after bariatric surgery, where rate of weight loss at this stage are similar between the two procedures. Increased understanding of the changes in these important metabolic organs, will increase the investigators' understanding of mechanism of diabetes remission following bariatric surgery, their effects on weight loss or changes in gut hormones levels. Magnetic Resonance imaging (MRI) and Magnetic Resonance spectroscopy (MRS) are non-invasive, non-ionising techniques. MRI can be used to investigate the body's physiology and MRS can be used to investigate the body's metabolic processes, so by combining these two methods the investigators are able to investigate the process of fat reduction and diabetes remission post gastric surgery without performing any secondary invasive procedures The purpose of this project is to investigate the effects of a Very Low Calorie Diet (VLCD) followed by two different bariatric surgical procedures, Roux-en-Y Gastric Bypass (RYGB) and Sleeve gastrectomy (SG) on skeletal muscle, liver and pancreatic fat deposition, ATP flux as well as cardiac function.

NCT ID: NCT05090488 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Integration of Health Coaching and Diabetes Education in Type 2 Diabetes Mellitus Management at Primary Health Care

Start date: December 14, 2020
Phase: N/A
Study type: Interventional

Type 2 Diabetes Mellitus is a chronic disease with increasing incidence globally. It needs a comprehensive and continuous management approach that includes five pillars: education, nutritional management, physical activity, pharmacological treatment, and monitoring. To achieve good glycemic control, prevention of complications, and good quality of life as diabetes management goals, patients' capability to properly navigate diabetes management is a key. One evidence-based model to empower patients' self-management abilities is diabetes education and health coaching. Diabetes management at primary health care needs special concern since they play an important role in initial and continuing care for diabetes patients in the community. Therefore, the implementation of diabetes education and health coaching in primary health care is expected to improve the self-management abilities of people with diabetes

NCT ID: NCT05089942 Not yet recruiting - Type2 Diabetes Clinical Trials

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Start date: December 2021
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate the efficacy,safety, and tolerability of the recombinant human insulin patch ZJSRM2021 in healthy subjects, type 1diabetes mellitus and type 2diabetes mellitus patients